WellO2 chose Innokas Medical as their partner for the product development project to further develop their breathing exercise device.

‍

Mattelmäki says that the cooperation between WellO2 and Innokas Medical has started well. He sees that Innokas will be able to create significant added value for WellO2 through the company’s long-term design and development experience. “Especially Innokas Medical’s agile development process, wide-ranging competence pool and references in implementing similar type of design projects were key factors when choosing a partner,” Tuomas Mattelmäki, CEO at WellO2, says and continues: “We also feel that through this cooperation and Innokas Medical’s strong expertise, our own understanding of carrying out a product development project like this will increase significantly. As a whole, it can be said that cooperation with Innokas creates us clear added value.”

‍

WellO2, innovation developed by the Finnish company WellO2 Oy (formerly known as Hapella Oy), is a breathing exercise device that strengthens and cleanses the lungs. The mission of the company is to promote the respiratory health of, for example, elderly, athletes, singers and people with different kinds of respiratory problems.